Back
Greenpro Capital Vs. Axsome Therapeutics Industry Stock Comparison
Sell
33
GRNQ
Greenpro Capital
Last Price:
$0.88
Seasonality Move:
55.03%
Sell
47
AXSM
Axsome Therapeutics
Last Price:
$118.50
Seasonality Move:
19.74%
Sell
33
Greenpro Capital (GRNQ)
is a Sell
Is Greenpro Capital a Buy, Sell or Hold?
-
The current Greenpro Capital [GRNQ] share price is $0.92. The Score for GRNQ is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
GRNQ is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
Axsome Therapeutics (AXSM)
is a Sell
Is Axsome Therapeutics a Buy, Sell or Hold?
-
The current Axsome Therapeutics [AXSM] share price is $118.53. The Score for AXSM is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
AXSM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GRNQ Stock Price Chart
What is Greenpro Capital's stock price today?
-
The Greenpro Capital share price today is $0.92Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GRNQ is experiencing slight selling pressure.
AXSM Stock Price Chart
What is Axsome Therapeutics's stock price today?
-
The Axsome Therapeutics share price today is $118.53The current trend is moderately bearish and AXSM is experiencing selling pressure, which indicates risk of future bearish movement.
GRNQ Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 44.88 | Sell |
Chaikin Money Flow: | -1947 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.9 - 0.96) | Sell |
Bollinger Bands (100): | (0.9 - 1.16) | Sell |
AXSM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.62 | Buy |
Relative Strength Index (14 RSI): | 44.34 | Sell |
Chaikin Money Flow: | -342463 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (120.72 - 129.02) | Sell |
Bollinger Bands (100): | (88.92 - 120.8) | Buy |
GRNQ Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.91 | Buy |
20-day SMA: | 0.92 | Sell |
50-day SMA: | 0.99 | Sell |
200-day SMA: | 1 | Sell |
8-day EMA: | 0.91 | Buy |
20-day EMA: | 0.93 | Sell |
50-day EMA: | 0.98 | Sell |
200-day EMA: | 1.04 | Sell |
AXSM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 123.49 | Sell |
20-day SMA: | 123.64 | Sell |
50-day SMA: | 117.5 | Buy |
200-day SMA: | 95.28 | Buy |
8-day EMA: | 122.09 | Sell |
20-day EMA: | 122.82 | Sell |
50-day EMA: | 117.2 | Buy |
200-day EMA: | 98.97 | Buy |
Greenpro Capital Earnings Growth & GRNQ Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Axsome Therapeutics Earnings Growth & AXSM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.59 per share, an increase next quarter of $0.25 per share, an increase this year of $1.54 per share, and an increase next year of $5.14 per share.
Greenpro Capital Technical Analysis
Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Axsome Therapeutics Technical Analysis
Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |